As of 2024-12-14, the Intrinsic Value of IGEA Pharma NV (IGPH.SW) is
0.01 CHF. This IGPH.SW valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.00 CHF, the upside of IGEA Pharma NV is
759.92%.
IGPH.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
0.01 - 0.01 |
0.01 |
759.92% |
P/E |
0.04 - 0.09 |
0.06 |
4139.4% |
DDM - Stable |
0.03 - 0.10 |
0.06 |
4151.8% |
DDM - Multi |
(0.26) - (0.77) |
(0.39) |
-26240.1% |
IGPH.SW Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
0.67 |
Beta |
-2.61 |
Outstanding shares (mil) |
449.37 |
Enterprise Value (mil) |
1.06 |
Market risk premium |
5.10% |
Cost of Equity |
4.94% |
Cost of Debt |
5.00% |
WACC |
4.40% |